FDA Drug Application (015103) for REGROTON by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number015103
Product Number001
FormTABLET;ORAL
Dosage50MG;0.25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREGROTON
Active IngredientCHLORTHALIDONE; RESERPINE



Back to FDA Applications sponsored by SANOFI AVENTIS US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.